*Specification

LACTOPY slimⅡNew lactobacillus diet! Healthy weight management.

●   Contains more 4 billion plant-originated lactobacillus per sachet

●   Contains garcinia cambogia, an inhibitor of fat synthesis

●   Helps intestinal beneficial bacteria proliferate and restraints harmful bacteria growth

●   Improves intestinal environment and helps regular bowel movement

●   3.5g * 28 stick (4 weeks) / Take 1 stick a day

*Company introduction

ProBionic was formed in 2000 as an independent venture company

by Korea Research Institute of Bioscience and Biotechnology (KRIBB) to promote the commercialization

of Institute inventions through licensing of technology and holds a National Research Laboratory (NRL)

on molecular microbial ecosystematics authorized by the Korean Government. The proBionic is dedicated to

become a global leader in the research and development of biotechnologies designed to discover and apply

new microorganisms and genes from diverse sources including human, animal, plant and environmental sources.

ProBionic executes a fully integrated approach, in the development of novel microorganisms and biologically

active compounds, such as new functional probiotics and small biomolecules.

Our platform technologies facilitate the optimization of novel microorganisms and genes found in nature to

enable product solutions for the Dermo-cosmetic, pharmaceutical, food industrial, environmental, and agricultural markets.

ProBionic is targeting key multi-billion dollar segments where the company believes its technologies and products

will create high value and competitive advantages for strategic partners and customers.

Since our founding in 2000, proBionic has emerged as a leader in the molecular systematics of microorganisms

for the creation of improved new functional probiotics and microbial products. For example, we contributed the

largest share in the world of the industrial starters for Kimchi fermentation. Recently, we completed the development

of the functional plant origin Latobacillus sakei probio65 whose phase III study was completed for the atopic dermatitis.

We have a strong pipeline of potential products including personalized medical healthcare in commercial market.

In addition to that, our high-quality products have been directly provided to our customers through the internet

shopping malls, www.probio65.com Our strategic partners and major customers are market

leaders including Daesang FNF, Pulmuwon Co., Cargill Purina Inc., CJ Corp., Theragen Bio Institute, and Genomictree Co.

We are also looking forward to the promising results obtained in the production of bio-energy through the

utilization of algae as our venture in future.